4//SEC Filing
Gauthier George 4
Accession 0001209191-23-051743
CIK 0001496323other
Filed
Oct 2, 8:00 PM ET
Accepted
Oct 3, 7:55 PM ET
Size
5.6 KB
Accession
0001209191-23-051743
Insider Transaction Report
Form 4
Gauthier George
Chief Commercial Officer
Transactions
- Sale
Common Stock
2023-10-02$7.95/sh−935$7,430→ 39,082 total
Footnotes (2)
- [F1]The sale reported by the Reporting Person was effected pursuant to a Rule 10b5-1 trading plan, entered into on December 29, 2022, prior to the effectiveness of the revised requirements of Rule 10b5-1(c). In compliance with SEC guidance, the Reporting Person has not checked the box above but states that the Rule 10b5-1 trading plan is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
- [F2]This transaction was executed in multiple trades at prices ranging from $7.80 to $8.31. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
Documents
Issuer
IGM Biosciences, Inc.
CIK 0001496323
Entity typeother
Related Parties
1- filerCIK 0001857434
Filing Metadata
- Form type
- 4
- Filed
- Oct 2, 8:00 PM ET
- Accepted
- Oct 3, 7:55 PM ET
- Size
- 5.6 KB